AI summary · may contain errors
Transcatheter tricuspid-valve repair plus medical therapy improves a 1-year hierarchical composite outcome in 360 patients with symptomatic severe tricuspid regurgitation, with a win ratio of 2.42.
- 21 cites
Moving in New England Journal of Medicine.
Rebuilt
AI summary · may contain errors
Transcatheter tricuspid-valve repair plus medical therapy improves a 1-year hierarchical composite outcome in 360 patients with symptomatic severe tricuspid regurgitation, with a win ratio of 2.42.
Newest first · last 60 days
AI summary · may contain errors
Cardiac computed tomography (CCT) is positioned as an established tool for managing heart disease, with guidance on indications, prognostic value, and practical limitations across multiple cardiac conditions.
AI summary · may contain errors
Right ventricular dysfunction is a key determinant of outcomes in valvular heart disease, with tricuspid regurgitation–associated dysfunction identifying patients at risk of worse post-intervention RV function.
AI summary · may contain errors
In symptomatic paradoxical low-flow, low-gradient aortic stenosis, TAVR plus optimal medical therapy did not significantly reduce 2-year all-cause mortality versus optimal medical therapy alone (29.0% vs 37.1%).
AI summary · may contain errors
In the ENCIRCLE MAC Registry, transseptal TMVR with the SAPIEN M3 system achieved MR ≤1+ in 98.5% of implanted patients at 1 year for symptomatic MAC-related MVD.
AI summary · may contain errors
Three months of DOAC therapy after TAVR reduced hypoattenuated leaflet thickening (HALT) at 3 months versus lifelong single antiplatelet therapy, 12.1% vs 31.8%.
AI summary · may contain errors
PIEZO1 and PIEZO2 are present in human mitral valve interstitial cells, and PIEZO1 activation with Yoda1 increases Ca2+ uptake and 5-HT signaling while PIEZO2-siRNA reduces tension-driven 5-HT production.
AI summary · may contain errors
Left ventricular outflow tract obstruction (LVOTO) is a catastrophic complication of transcatheter mitral valve replacement, occurring in 0%–40% of procedures and linked to up to 36% mortality.
AI summary · may contain errors
Transcatheter mitral valve replacement with the SAPIEN M3 system in ENCIRCLE’s high-risk symptomatic mitral regurgitation cohort sustained MR ≤1+ in 97.0% at 2 years.
AI summary · may contain errors
In a randomized trial of transfemoral TAVR in China, single-ProGlide closure was noninferior to double-ProGlide for VARC-3 access-site or access-related vascular complications (13.1% vs 15.1%).
AI summary · may contain errors
Routine postdilation during balloon-expandable TAVI in severe aortic stenosis reduced THV asymmetry index by 70% versus no postdilation (1.2% vs 2.8%; P < .001).
AI summary · may contain errors
Gas6 promotes terminal scission of mitochondrial-derived vesicles in calcifying human valvular interstitial cells, enabling recipient-cell calcification and linking to Ca2+-CaMKII-DRP1 signaling.
AI summary · may contain errors
A deep learning algorithm detected moderate or greater aortic stenosis on AI-guided focused cardiac ultrasound with AUROC 0.99 (95% CI 0.96–1.00) in Florida validation.
AI summary · may contain errors
In newly diagnosed transthyretin amyloid cardiomyopathy, quantitative tricuspid regurgitation thresholds (VCW, EROA, RegVol) stratify mortality and HF hospitalization, with extreme risk at VCW ≥8 mm.
Journals this month
Topics moving, week to 17 Nov 2026
By field